

Detail-oriented Clinical Research Professional with 9 years in clinical trial management, excelling in study start-up, site management, and data verification. Ensures compliance with ICH-GCP and regulatory standards while enhancing study efficiency through effective collaboration with investigators, sponsors, and cross-functional teams. Manages multiple projects, resolves site-level issues, and maintains oversight to uphold data integrity throughout clinical trials
• Conducted centralized monitoring across multiple global clinical trials in accordance with approved monitoring and risk-based monitoring
plans.
• Performed site-, country- and study-level risk assessments using clinical data, KRIs and performance trends to identify early signals.
quality risks and potential delivery issues.
• Analyzed clinical data through centralized monitoring platforms and analytics tools to identify inconsistencies, data-quality risks.
protocol/compliance signals and performance trends.
• Communicated findings, risks, escalations and recommended mitigation/follow-up actions to study teams, supporting proactive issue
management and study oversight.
• Documented centralized monitoring reviews and follow-up actions to support audit/inspection readiness and traceability of study-level
risk management.
• Supported development and maintenance of KRI dashboards and centralized monitoring logic, strengthening analytics workflows and
consistent risk review.
• Contributed to training and knowledge-sharing on centralized monitoring and RBM best practices.
Coordinated day-to-day clinical trial activities in accordance with protocol, ICH-GCP and regulatory requirements, supporting participant safety and trial integrity. • Managed participant screening, recruitment, scheduling, visits, follow-up and informed-consent documentation. • Maintained source documentation, entered study data into EDC systems, resolved data queries and collaborated with investigators. sponsors and monitors for maintaining data quality. • Prepared and maintained essential documents, regulatory binders, and TMF documentation to ensure audit and inspection readiness. • Coordinated monitoring visits, audits, sponsor communications and action-item follow-up; reported AEs, SAEs and protocol deviations according to study and regulatory requirements.